(Q44221699)

1 December 2017

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases (English)

1 reference

1 December 2017

1 reference

Tuya Pal

1

1 reference

1 December 2017

Jenny Permuth-Wey

2

1 reference

1 December 2017

Judith A Betts

3

1 reference

1 December 2017

Jeffrey P Krischer

4

1 reference

1 December 2017

James Fiorica

5

1 reference

1 December 2017

Hector Arango

6

1 reference

1 December 2017

James LaPolla

7

1 reference

1 December 2017

Mitchell Hoffman

8

1 reference

1 December 2017

Martin A Martino

9

1 reference

1 December 2017

Katie Wakeley

10

1 reference

1 December 2017

George Wilbanks

11

1 reference

1 December 2017

Santo Nicosia

12

1 reference

1 December 2017

Alan Cantor

13

1 reference

1 December 2017

Rebecca Sutphen

14

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

1 December 2017

1 reference

1 December 2017

104

1 reference

1 December 2017

2807-2816

1 reference

1 December 2017

12

1 reference

Characteristics relating to ovarian cancer risk: implications for prevention and detection

1 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Hereditary ovarian cancer in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

How accurate is self-reported family history of colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Improved survival in women with BRCA-associated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Contribution of BRCA1 mutations to ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

The accuracy of patient reports of a family history of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Validation of family history of cancer in deceased family members

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Accuracy of cancer family histories: comparison of two breast cancer syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21536

7 January 2021

Identifiers

DOI

10.1002/CNCR.21536

1 reference

release_ijt6j5poszflzikn6hunzwxgpy

1 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ijt6j5poszflzikn6hunzwxgpy

24 November 2022

mapped directly with Wikidata item

1 reference